Archit Organosys Ltd
Incorporated in 1989, Archit Organosys Ltd
does manufacturing and trading of chemicals
and organics[1]
- Market Cap ₹ 140 Cr.
- Current Price ₹ 68.4
- High / Low ₹ 72.0 / 34.0
- Stock P/E 18.9
- Book Value ₹ 38.6
- Dividend Yield 1.46 %
- ROCE 13.8 %
- ROE 11.4 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is expected to give good quarter
Cons
- The company has delivered a poor sales growth of 8.32% over past five years.
- Company has a low return on equity of 6.84% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Chemicals & Petrochemicals Commodity Chemicals
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56 | 51 | 48 | 82 | 84 | 77 | 95 | 138 | 128 | 113 | 126 | 141 | 176 | |
| Sales growth | +13% | -8% | -6% | +70% | +3% | -9% | +23% | +46% | -7% | -11% | +11% | +12% | +30% |
| 53 | 48 | 44 | 78 | 87 | 73 | 83 | 121 | 108 | 106 | 113 | 124 | 160 | |
| Operating Profit | 2 | 3 | 4 | 4 | -3 | 4 | 11 | 17 | 20 | 7 | 13 | 17 | 16 |
| OPM % | 4.0% | 6% | 8% | 4.6% | -3.6% | 4.6% | 12% | 12% | 15% | 6% | 10% | 12% | 9% |
| 1 | 1 | 0 | 3 | 3 | 2 | 0 | 1 | 3 | 6 | 3 | 3 | 2 | |
| Interest | 1 | 1 | 1 | 4 | 4 | 3 | 3 | 2 | 2 | 3 | 3 | 2 | 2 |
| Depreciation | 0 | 0 | 1 | 3 | 3 | 3 | 4 | 5 | 5 | 6 | 6 | 6 | 6 |
| Profit before tax | 1 | 2 | 3 | 0 | -6 | -1 | 5 | 11 | 15 | 4 | 8 | 11 | 10 |
| Tax % | 43% | 37% | 42% | -32% | -25% | 1% | -7% | 28% | 26% | 24% | 33% | 27% | |
| 1 | 1 | 2 | 1 | -5 | -1 | 5 | 8 | 11 | 3 | 5 | 8 | 7 | |
| EPS in Rs | 1.38 | 1.53 | 1.14 | 0.34 | -3.14 | -0.53 | 3.34 | 4.01 | 5.57 | 1.63 | 2.46 | 3.91 | 3.62 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 15% | 19% | 9% | 0% | 20% | 26% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 3% |
| TTM: | 30% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 19% |
| 5 Years: | 10% |
| 3 Years: | -5% |
| TTM: | 13% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 10% |
| 3 Years: | 8% |
| 1 Year: | 48% |
| Return on Equity | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 11% |
| 3 Years: | 7% |
| Last Year: | 11% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 10 | 15 | 15 | 15 | 15 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves | 2 | 8 | 17 | 25 | 20 | 19 | 26 | 31 | 41 | 44 | 49 | 56 | 59 |
| 9 | 11 | 31 | 36 | 37 | 33 | 30 | 34 | 31 | 26 | 28 | 25 | 8 | |
| 10 | 8 | 12 | 26 | 12 | 16 | 17 | 18 | 27 | 18 | 26 | 25 | 44 | |
| Total Liabilities | 24 | 32 | 70 | 101 | 84 | 83 | 87 | 104 | 120 | 108 | 123 | 127 | 131 |
| 6 | 6 | 47 | 47 | 47 | 50 | 48 | 45 | 50 | 60 | 54 | 50 | 47 | |
| CWIP | 0 | 8 | 1 | 8 | 5 | 1 | 3 | 13 | 14 | 1 | 1 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | 6 | 6 | 7 | 7 |
| 18 | 18 | 22 | 46 | 32 | 32 | 37 | 44 | 52 | 42 | 62 | 70 | 77 | |
| Total Assets | 24 | 32 | 70 | 101 | 84 | 83 | 87 | 104 | 120 | 108 | 123 | 127 | 131 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 1 | 2 | -4 | 3 | 8 | 11 | 11 | 18 | 10 | 19 | 3 | |
| -2 | -8 | -35 | -9 | 1 | -1 | -3 | -12 | -12 | -2 | -21 | 4 | |
| 1 | 7 | 32 | 13 | 0 | -9 | -7 | 2 | -7 | -9 | -1 | -6 | |
| Net Cash Flow | 0 | -0 | -0 | 0 | 4 | -2 | 1 | 2 | -0 | -1 | -4 | 1 |
| Free Cash Flow | -0 | -7 | -32 | -13 | 3 | 6 | 8 | -0 | 9 | 15 | 18 | 1 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 93% | 57% | 75% | -90% | -97% | 221% | 99% | 71% | 108% | 164% | 150% | 29% |
Ratios
Standalone / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 76 | 79 | 86 | 140 | 62 | 94 | 97 | 72 | 107 | 72 | 67 | 64 |
| Inventory Days | 28 | 28 | 27 | 41 | 30 | 22 | 21 | 22 | 16 | 16 | 18 | 11 |
| Days Payable | 72 | 63 | 80 | 126 | 55 | 88 | 87 | 51 | 110 | 62 | 91 | 65 |
| Cash Conversion Cycle | 33 | 44 | 33 | 56 | 38 | 28 | 30 | 44 | 13 | 26 | -6 | 10 |
| Working Capital Days | -1 | 3 | 19 | 12 | -23 | -39 | -15 | -0 | 10 | 10 | 45 | 40 |
| ROCE % | 20% | 17% | 9% | 6% | -4% | 3% | 12% | 18% | 17% | 4% | 11% | 14% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Export Share of Revenue % of revenue |
|
|||||||||||
| Installed Capacity MTPA |
||||||||||||
| Manufacturing Share of Revenue % of sale of products |
||||||||||||
| Number of Permanent Employees employees |
||||||||||||
| CAC Share of Manufactured Goods Revenue % of manufactured goods |
||||||||||||
| MCA Share of Manufactured Goods Revenue % of manufactured goods |
||||||||||||
Extracted by Screener AI
Documents
Announcements
- Results: Un-Audited Financial Result For Quarter And Half Year Ended On September 30, 2026.
-
Board Meeting Outcome for Outcome Of Board Meeting
- Q2 FY27 unaudited results approved; H1 revenue ₹10,107.70 lakh and net profit ₹299.07 lakh.
-
Board Meeting Intimation for Intimation Of Board Meeting
- Board meeting on November 4, 2026 to approve Q2 and half-year unaudited financial results.
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2015
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
Business Overview:[1][2]
AOL manufactures a variety of Organic Chemicals, Pigments, Specialty Derivatives, Adhesives, and sealants viz. mono chloroacetic acid, sodium chloroacetate that is used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals,
and plastic additives, etc.
It also entered into the Adhesives & Sealants segment by the brand AOL which offers various range of Sealants